Results 91 to 100 of about 298,497 (207)

Gastritis crónica en el Hospital San Juan de Dios y Clínica Carlos Lleras Restrepo de Bogotá, Universidad Nacional de Colombia

Revista de la Facultad de Medicina, 2002
The inflammatory gastric pathology is a very important cause of morbidity in Colombia. Specific conditions sucb as multifocal atrophic chronic gastritis, intestinal metaplasia and dysplasia are associated with the development of gastric adenocarcinoma of
Mauricio A. Paláu, Viviana L. Arias, Juan José Yunis, Diana Palacios, Orlando Ricaurte   +4 more
doaj  

The Prevalence of Helicobacter pylori Infection Decreases with Older Age in Atrophic Gastritis

Gastroenterology Research and Practice, 2013
The clinical pathological characteristics of 3969 adult patients with chronic atrophic gastritis were retrospectively studied. The positivity of intestinal metaplasia and dysplasia in atrophic gastric specimens increased with age; however, H.
Shaohua Chen, Lixiong Ying, Mei Kong, Yu Zhang, Youming Li   +4 more
doaj   +1 more source

A Liquid Thickener Presentation Format for the Therapeutic Management of Dysphagia—A Promising Step Forward in Addressing the Challenges Associated With Thickened Fluids in Swallowing Disorders?

International Journal of Language &Communication Disorders, Volume 61, Issue 1, January/February 2026.
ABSTRACT Introduction Thickening fluids in routine care of patients with Oropharyngeal dysphagia (OD) can improve swallow safety but may be counteracted by reduced palatability, enjoyment, embarrassment, and isolation related to drinking thickened fluids (TFs).
Natascha Ullrich, Brenda Mossel, Sue Pownall, Jo Burke, Helena Perry, Heather Robinson, John Stephenson   +6 more
wiley   +1 more source

Changes of gastric microflora and metabolites in patients with chronic atrophic gastritis

Journal of Translational Medicine
Background Chronic atrophic gastritis (CAG) is related to the body’s microbial and metabolic systems. Combined studies of microbiome and metabolomics can clarify the mechanisms of disease occurrence and progression.
Yumei Ma, Jianming Jiang, Zhufeng Yang, Yongzhang Li, Haiyan Bai, Zongxiu Liu, Shuo Zhang, Zheng Zhi, Qian Yang   +8 more
doaj   +1 more source

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial [PDF]

, 2004
BACKGROUND: Helicobacter pylori gastritis may progress to glandular atrophy and intestinal metaplasia, conditions that predispose to gastric cancer.
Dent, J., Festen, H.P., Goldfain, D., Havu, N., Klinkenberg-Knol, E.C., Kolkman, J.J. (Jeroen), Kuipers, E.J. (Ernst), Lamm, M., Nelis, G.F., Snel, P., Walan, A., Zeitoun, P.   +11 more
core   +5 more sources

Clinical case of autoimmune atrophic gastritis

Клинический разбор в общей медицине
The article presents a clinical case of a 62-year-old female patient with a diagnosis of autoimmune atrophic gastritis, who has been troubled by symptoms of dyspepsia for 5 years.
Natalya N. Dekhnich , Pavel Р. Kirsov , Inna A. Sysoeva, Anastasiia S. Gaidaichuk   +3 more
doaj   +1 more source

Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.

PLoS ONE, 2020
Serum pepsinogens have been widely acknowledged as gastric mucosal biomarkers; however, a multicountry report on the benefits of pepsinogens as biomarkers has not yet been published.
Muhammad Miftahussurur, Langgeng Agung Waskito, Hafeza Aftab, Ratha-Korn Vilaichone, Phawinee Subsomwong, Iswan Abbas Nusi, Ari Fahrial Syam, Thawee Ratanachu-Ek, Dalla Doohan, Gontar Siregar, Yudith Annisa Ayu Rezkitha, Kartika Afrida Fauzia, Varocha Mahachai, Yoshio Yamaoka   +13 more
doaj   +1 more source

Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes [PDF]

, 2015
The bacterial pathogen Helicobacter pylori commonly colonizes the human gastric mucosa during early childhood and persists throughout life. The organism has evolved multiple mechanisms for evading clearance by the immune system and, despite inducing ...
Robinson, K, White, JR, Winter, JA
core   +1 more source

Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial

Helicobacter, Volume 31, Issue 1, January/February 2026.
ABSTRACT Background Tegoprazan, a potassium‐competitive acid blocker, offers potent and sustained acid inhibition and potentially improves eradication efficacy. Aim This study aimed to evaluate the efficacy and safety of tegoprazan‐based triple therapy with two dosing regimens compared with that of lansoprazole‐based therapy for first‐line Helicobacter
Jae Yong Park, Su Jin Hong, Il Ju Choi, Gwang Ho Baik, Sun Moon Kim, Jong‐Jae Park, Seong Woo Jeon, Kyung‐Oh Kim, Sang Kil Lee, Hwoon‐Yong Jung, Jung‐Hwan Oh, Chan Hyuk Park, Sang Wook Kim, Ki‐Nam Shim, Sam Ryong Jee, Hee Seok Moon, Jeong Seop Moon, Cheol Woong Choi, Wan‐Sik Lee, Jae Gyu Kim   +19 more
wiley   +1 more source

A case of Metaplastic atrophic gastritis in immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome

BMC Pediatrics, 2018
Background Autoimmune metaplastic atrophic gastritis is a chronic progressive inflammatory condition. The clinical spectrum includes pernicious anemia, atrophic gastritis, antibodies to parietal cell antigens and intrinsic factor, achlorhydria ...
Youyou Luo, Jie Chen, Youhong Fang, Jingan Lou, Jindan Yu   +4 more
doaj   +1 more source